<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01645475</url>
  </required_header>
  <id_info>
    <org_study_id>2010/247</org_study_id>
    <nct_id>NCT01645475</nct_id>
  </id_info>
  <brief_title>Desmopressin Melt: Impact on Sleep and Daytime Functioning</brief_title>
  <acronym>SLEEP</acronym>
  <official_title>Desmopressin Melt: Impact on Sleep and Daytime Functioning? A Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ferring Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nocturnal enuresis affects 10% of the 7-year-old children and is essentially caused by a
      mismatch between nocturnal bladder capacity and the amount of urine produced during the night
      together with failure of the child to awaken in response to a full bladder.Urine
      overproduction at night or nocturnal polyuria (NP) is a major factor contributing to
      monosymptomatic nocturnal enuresis (MNE) pathophysiology in a large proportion of patients.

      Since NP is related to an abnormal circadian rhythm of arginine vasopressin (AVP) secretion,
      the synthetic AVP analogue desmopressin is widely used to treat MNE.

      It is recommended by the International Consultation on Incontinence (grade A,level 1).
      Desmopressin is available in 3 different formulations: nasal spray, tablet and the newest
      form melt.

      Baeyens et al demonstrated an increased prevalence of attention deficit-hyperactivity
      disorder (ADHD) in children with MNE According to recent data there is a high incidence of
      periodic limb movements in sleep at night in children with nocturnal enuresis. Those children
      have an increased cortical arousability leading to awakening.

      The frequent awakening most likely has an influence on concentration and other ADHD-symptoms
      in daily life.

      This study will assess the impact of desmopressin melt on prepulse inhibition, ADHD-symptoms,
      cognition and learning, sleep, quality of life and self esteem.

      New patients aged 6-16 years with monosymptomatic nocturnal enuresis, nocturnal polyuria and
      sleep problems are tested before the start of the study medication desmopressin melt (T1) and
      6 months later (T2). It is a multi-method, multi-informant study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bladder information: voiding calender</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Voiding calendar</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine concentration</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Forced diuresis and 24h concentration profile with measurement of Na, K, creatinin, osmolality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IQ (Intelligent Quotient)</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Wechsler Intelligence Scale for Children-Third Edition (WISC-III) short version</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Child Behavior Checklist - CBCL (parents)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>&quot;Vragenlijst voor Gedragsproblemen bij Kinderen&quot; (VvGK): questionnaire to screen for ADHD and behavioral disorders (parents, teacher)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>TRF: Teacher Report Form (teacher)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Behavior Rating Inventory of Executive Function (BRIEF): questionnaire to assess executive functions) (parents, teacher)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Pediatric Incontinence Questionniare (PinQ): questionnaire to measure health related quality of life, specific enuresis (parents + child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Pediatric Quality of Life Inventory (PedsQL): questionnaire to measure health related quality of life (parents + child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Kiddie Schedule for Affective Disorders and Schizofrenia (K-SADS): diagnostic interview if CBCL/TRF is (sub)clinical (parents + child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Cambridge Neuropsychological Test Automated Battery (CANTAB) (child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>IQ: WISC-III subtest Digit Span - children are orally given sequences of numbers and asked to repeat them, either as heard or in reverse order. (child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Test of Everyday Attention for Children (TEA-ch): subtest Secret code + Score DT (sustained attention task) (child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>&quot;Competentiebelevingsschaal voor Kinderen/Adolescenten&quot; (CBSK/CBSA): questionnaire to measure self-esteem in children or adolescents OR The pictorial scale of perceived competence and social acceptance for young children. (child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Swanson, Kotkin, Agler, Mylnn, and Pelham (SKAMP) Rating Scale: observation scale (teacher)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychological functioning questionnaire</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>School results: copy of schoolreport (+median) (teacher)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Pediatric Sleep Questionnaire (questionnaire to assess the quality of sleep) (parents)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Children's Sleep Habits Questionnaire (CSHQ) (parents)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep</measure>
    <time_frame>Change between day 1 before start of studymedication and 6 months later</time_frame>
    <description>Polysomnography (overnight hospitalization) (child)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Monosymptomatic Nocturnal Enuresis.</condition>
  <arm_group>
    <arm_group_label>Desmopressin lyophilisate (Melt)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving Desmopressin lyophilisate (Melt).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desmopressin lyophilisate (Melt)</intervention_name>
    <description>Patient receives Desmopressin lyophilisate (Melt).</description>
    <arm_group_label>Desmopressin lyophilisate (Melt)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  New patient

          -  age 6 to 16 years

          -  monosymptomatic nocturnal enuresis, nocturnal polyuria and sleep problems

        Exclusion Criteria:

          -  mental retardation

          -  autism spectrum disorders

          -  daytime incontinence resistant to therapy

          -  dysfunctional voiding

          -  poor therapy-compliance

          -  diuretics, antihypertensives, uropathy, renal abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johan Vande Walle, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
  </link>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2012</study_first_posted>
  <last_update_submitted>December 4, 2014</last_update_submitted>
  <last_update_submitted_qc>December 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>enuresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

